Thrombosis and Haemostasis · 1997 · 278 citations · 18 references
MedicineGeneticsHematologyEpidemiologic MethodsEpidemiologyHuman GeneticsCase-control StudiesGenetic RiskGenetic Risk FactorsRisk Factor EpidemiologyThrombosisThrombotic DisordersCase-control Study DesignFactor V Leiden ThrombophiliaGenetic ThrombophiliaIncidence RateIncidence Rate RatioThrombophilia Risk AssessmentThrombotic Risk AssessmentVenous Thromboembolism Epidemiology
Study Design (5) LETS was designed to assess the importance at the population level of various risk factors for thrombosis, many of which had been identified by family studies. Generally, two approaches are possible: cohort studies and case-control studies. In the former, patients with and without a risk factor are followed over time, and absolute risks (probability of disease, incidence) and relative risks (incidence rate ratio) can be calculated. In a case-control study, patients with thrombosis and healthy controls are included, and relative risks (odds ratios) can be calculated. Due to the rarity of the genetic risk factors for thrombosis, a follow-up study of a truly unselected sample from the
18
Mutation in blood coagulation factor V associated with resistance to activated protein C
Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al. · Nature · 1994 · 3.8K citations
Medicine, Genetics, Hematology +14
Ted Koster, FR Rosendaal, Hans de Ronde et al. · The Lancet · 1993 · 1.3K citations
Medicine, Hematology, Hemostasis +14
Deficiency of protein C in congenital thrombotic disease.
John H. Griffin, B. L. Evatt, T S Zimmerman et al. · Journal of Clinical Investigation · 1981 · 1.3K citations · Full text
Medicine, Genetics, Hematology +14
Ted Koster, Jan P. Vandenbroucke, F. R. Rosendaal et al. · The Lancet · 1995 · 1.1K citations
Medicine, Hematology, Pathology +14